Loading...

Prescient Therapeutics Limited

PSTTFPNK
Healthcare
Biotechnology
$0.14
$0.00(0.00%)

Prescient Therapeutics Limited (PSTTF) Stock Competitors & Peer Comparison

See (PSTTF) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
PSTTF$0.15+0.00%117.5M-29.00-$0.01N/A
NONOF$54.70-20.50%240.2B14.83$3.65+3.02%
CSLLY$88.85+1.05%173.2B32.88$2.72+1.49%
CMXHF$173.54+0.31%84B32.38$5.36+1.60%
UCBJF$218.19+2.92%41.5B34.09$6.40+0.73%
UCBJY$106.80+3.20%41.4B33.55$3.19+0.74%
ARGNF$547.60+0.00%33.5B33.45$16.37N/A
ODTC$22,005.00+29.44%24.1B1.07$20,580.00N/A
IVBXF$12.27+1.66%21.6B-1261.00-$0.01N/A
WXXWY$8.42+4.60%17.2B38.27$0.22N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

PSTTF vs NONOF Comparison July 2025

PSTTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PSTTF stands at 117.5M. In comparison, NONOF has a market cap of 240.2B. Regarding current trading prices, PSTTF is priced at $0.15, while NONOF trades at $54.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PSTTF currently has a P/E ratio of -29.00, whereas NONOF's P/E ratio is 14.83. In terms of profitability, PSTTF's ROE is N/A, compared to NONOF's ROE of +0.81%. Regarding short-term risk, PSTTF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for PSTTF.Check NONOF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;